Inferior vena cava ligation rapidly induces tissue factor expression and venous thrombosis in rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 29, Issue 6, 2009, Pages 863-869

  Zhou, Ji ^a,c   May, Linda ^a,c   Liao, Peng ^a,c   Gross, Peter L ^a,c   Weitz, Jeffrey I ^a,b,c  

^a Department of Medicine ^*  (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

Deep vein thrombosis; Inferior vena cava ligation; P selectin; Protein disulfide isomerase; Tissue factor

Indexed keywords

FIBRIN; PROTEIN DISULFIDE ISOMERASE; THROMBOPLASTIN; PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ENDOTHELIUM CELL; ERYTHROCYTE; IMMUNOHISTOCHEMISTRY; INFERIOR CAVA VEIN; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; THROMBOCYTE AGGREGATION; THROMBUS; VEIN DILATATION; VEIN LIGATION; VEIN WALL; ANIMAL; CELL ADHESION; DISEASE MODEL; LESIONS AND DEFECTS; LIGATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME; UPREGULATION; VEIN THROMBOSIS;

ANIMALS; CELL ADHESION; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; LEUKOCYTES; LIGATION; P-SELECTIN; PROTEIN DISULFIDE-ISOMERASES; RATS; RATS, SPRAGUE-DAWLEY; THROMBOPLASTIN; TIME FACTORS; UP-REGULATION; VENA CAVA, INFERIOR; VENOUS THROMBOSIS;

EID: 66349098390     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.185678     Document Type: Article

References (35)

1. Lilienfeld DE, Chan E, Ehland J, Godbold JH, Landrigan PJ, Marsh G. Mortality from pulmonary embolism in the United States: 1962 to 1984. Chest. 1990;98:1067-1072.
2. Lilienfeld DE. Decreasing mortality from pulmonary embolism in the United States, 1979-1996. Int J Epidemiol. 2000;29:465-469.
3. Coombes R. Venous thromboembolism caused 25000 deaths a year, say MPs. BMJ. 2005;330:559.
4. Kahn SR, Ginsberg JS. Relationship between deep venous thrombosis and the postthrombotic syndrome. Arch Intern Med. 2004;164:17-26.
5. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126:338S-400S.
6. Lopez JA, Kearon C, Lee AY. Deep venous thrombosis. Hematology Am Soc Hematol Educ Program. 2004;439-456.
7. Sevitt S. The structure and growth of valve-pocket thrombi in femoral veins. J Clin Pathol. 1974;27:517-528.
8. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
9. Morel O, Toti F, Hugel B, Bakouboula B, Camoin-Jau L, Dignat-George F, Freyssinet JM. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol. 2006;26: 2594-2604.
10. Bach RR. Tissue factor encryption. Arterioscler Thromb Vasc Biol. 2006; 26:456-461.
11. Manukyan D, von Bruehl ML, Massberg S, Engelmann B. Protein disulfide isomerase as a trigger for tissue factor-dependent fibrin generation. Thromb Res. 2008;122:S19-22.
12. Cho J, Furie BC, Coughlin SR, Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest. 2008;118:1123-1131.
13. Pendurthi UR, Ghosh S, Mandal SK, Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood. 2007;110: 3900-3908.
14. Mammen EF. Pathogenesis of venous thrombosis. Chest. 1992;102: 640S-644S.
15. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol. 1993;11:767-804.
16. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005;3:1590-1596.
17. Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol. 2008;28:387-391.
18. Hadcock S, Richardson M, Winocour PD, Hatton MWC. Intimal alterations in rabbit aortas during the first 6 months of alloxan-induced diabetes. Arteroscler Thromb. 1991;11:517-529.
19. Reinhardt C, von Bruuhl M, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mcckman N, Ruddock L, Massberg S, Engelmann B. Protein disulfide isomerase acts as injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest. 2008;118:1110-1122.
20. Stewart GJ. Neutrophils and deep venous thrombosis. Haemostasis. 1993; 23:127-140.
21. Margic K. Early changes in dissected small vessels: experimental study on rat arteries and veins. Plast Reconstr Surg. 1985;75:375-383.
22. Stewart GJ, Lachman JW, Alburger PD, Ziskin MC, Philips CM, Jensen K. Intraoperative venous dilation and subsequent development of deep vein thrombosis in patients undergoing total hip or knee replacement. Ultrasound Med Biol. 1990;16:133-140.
23. Comerota AJ, Stewart GJ, Alburger PD, Smalley K, White JV. Operative venodilation: A previously unsuspected factor in the cause of postoperative deep vein thrombosis. Surgery. 1989;106:301-309.
24. Lawson CA, Yan SD, Yan SF, Liao H, Zhou YS, Sobel J, Kisiel W, Stern DM, Pinsky DJ. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation. J Clin Invest. 1997;99:1729-1738.
25. de Waard V, Hansen HR, Spronk HH, Timmerman JJ, Pannekoek H, Florquin S, Reitsma PH, ten Cate H. Differential expression of tissue factor mRNA and protein expression in murine sepsis. The role of the granulocyte revisited. Thromb Haemost. 2006;95:348-353.
26. Day SM, Reeve JL, Pedersen B, Farris DM, Myers DD, Im M, Wakefield TW, Mackman N, Fay WP. Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall. Blood. 2005;105: 192-198.
27. Tesselaar ME, Romijn FP, VanDer Linden IK, Prins FA, Bertina RM, Osanto S. Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost. 2007;5:520-527.
28. Rectenwald JE, Myers DD Jr, Hawley AE, Longo C, Henke PK, Guire KE, Schmaier AH, Wakefield TW. D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost. 2005;94:1312-1317.
29. Chen K, Lin Y, Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood. 1992;79:2226-2228.
30. Sullivan VV, Hawley AE, Farris DM, Knipp BS, Varga AJ, Wrobleski SK, Thanapron P, Eagleton MJ, Myers DD, Fowles JB, Wakefield TW. Decrease in fibrin content of venous thrombi in selectin-deficient mice. J Surg Res. 2003;109:1-7.
31. Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ III, Fex BA, Chapman AM, Greenfielf LJ, Wakefield TW. P-selectin antagonism causes dosedependent venous thrombosis inhibition. Thromb Haemost. 2001;85: 423-429.
32. Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW. P-selectin and leukocyte microparticles are associated with venous thrombogenesis. J Vasc Surg. 2003;38:1075-1089.
33. Michiels C, Arnould T, Remacle J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta. 2000;1497:1-10.
34. Goerge T, Niemeyer A, Rogge P, Ossig R, Oberleithner H, Schneider SW. Secretion pores in human endothelial cells during acute hypoxia. J Membrane Biol. 2002;187:203-211.
35. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S.